The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice
Activation of the interleukin-4 (IL-4) pathway ameliorates secondary injury mechanisms after experimental traumatic brain injury (TBI); therefore, we assessed the effect of a therapeutic IL-4 administration on secondary brain damage after experimental TBI. We subjected 100 C57/Bl6 wildtype mice to c...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2023
|
| In: |
International journal of molecular sciences
Year: 2023, Jahrgang: 24, Heft: 16, Pages: 1-17 |
| ISSN: | 1422-0067 |
| DOI: | 10.3390/ijms241612756 |
| Online-Zugang: | Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms241612756 Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/24/16/12756 
|
| Verfasserangaben: | Johannes Walter, Jannis Mende, Samuel Hutagalung, Obada T. Alhalabi, Martin Grutza, Guoli Zheng, Thomas Skutella, Andreas Unterberg, Klaus Zweckberger and Alexander Younsi |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1865734195 | ||
| 003 | DE-627 | ||
| 005 | 20240307045843.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231016s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3390/ijms241612756 |2 doi | |
| 035 | |a (DE-627)1865734195 | ||
| 035 | |a (DE-599)KXP1865734195 | ||
| 035 | |a (OCoLC)1425210250 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Walter, Johannes |d 1990- |e VerfasserIn |0 (DE-588)1181398878 |0 (DE-627)1662669275 |4 aut | |
| 245 | 1 | 4 | |a The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice |c Johannes Walter, Jannis Mende, Samuel Hutagalung, Obada T. Alhalabi, Martin Grutza, Guoli Zheng, Thomas Skutella, Andreas Unterberg, Klaus Zweckberger and Alexander Younsi |
| 264 | 1 | |c 2023 | |
| 300 | |b Illustrationen | ||
| 300 | |a 17 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Veröffentlicht: 14. August 2023 | ||
| 500 | |a Gesehen am 16.10.2023 | ||
| 520 | |a Activation of the interleukin-4 (IL-4) pathway ameliorates secondary injury mechanisms after experimental traumatic brain injury (TBI); therefore, we assessed the effect of a therapeutic IL-4 administration on secondary brain damage after experimental TBI. We subjected 100 C57/Bl6 wildtype mice to controlled cortical impact (CCI) and administered IL-4 or a placebo control subcutaneously 15 min thereafter. Contusion volume (Nissl staining), neurological function (hole board, video open field, and CatWalkXT®), and the immune response (immunofluorescent staining) were analyzed up to 28 days post injury (dpi). Contusion volumes were significantly reduced after IL-4 treatment up to 14 dpi (e.g., 6.47 ± 0.41 mm3 vs. 3.80 ± 0.85 mm3, p = 0.011 3 dpi). Macrophage invasion and microglial response were significantly attenuated in the IL-4 group in the acute phase after CCI (e.g., 1.79 ± 0.15 Iba-1+/CD86+ cells/sROI vs. 1.06 ± 0.21 Iba-1/CD86+ cells/sROI, p = 0.030 in the penumbra 3 dpi), whereas we observed an increased neuroinflammation thereafter (e.g., mean GFAP intensity of 3296.04 ± 354.21 U vs. 6408.65 ± 999.54 U, p = 0.026 in the ipsilateral hippocampus 7 dpi). In terms of functional outcome, several gait parameters were improved in the acute phase following IL-4 treatment (e.g., a difference in max intensity of −7.58 ± 2.00 U vs. −2.71 ± 2.44 U, p = 0.041 3 dpi). In conclusion, the early single-dose administration of IL-4 significantly reduces secondary brain damage in the acute phase after experimental TBI in mice, which seems to be mediated by attenuation of macrophage and microglial invasion. | ||
| 650 | 4 | |a behavioral test | |
| 650 | 4 | |a CCI | |
| 650 | 4 | |a controlled cortical impact | |
| 650 | 4 | |a IL-4 | |
| 650 | 4 | |a immunomodulation | |
| 650 | 4 | |a inflammation | |
| 650 | 4 | |a interleukin-4 | |
| 650 | 4 | |a secondary brain damage | |
| 650 | 4 | |a TBI | |
| 650 | 4 | |a traumatic brain injury | |
| 700 | 1 | |a Mende, Jannis |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hutagalung, Samuel |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alhalabi, Obada |d 1994- |e VerfasserIn |0 (DE-588)1193522706 |0 (DE-627)167225941X |4 aut | |
| 700 | 1 | |a Grutza, Martin |d 1991- |e VerfasserIn |0 (DE-588)1218732377 |0 (DE-627)1734302739 |4 aut | |
| 700 | 1 | |a Zheng, Guoli |d 1989- |e VerfasserIn |0 (DE-588)1199567183 |0 (DE-627)1681875667 |4 aut | |
| 700 | 1 | |a Skutella, Thomas |d 1963- |e VerfasserIn |0 (DE-588)120568225 |0 (DE-627)080752047 |0 (DE-576)180448390 |4 aut | |
| 700 | 1 | |a Unterberg, Andreas |e VerfasserIn |0 (DE-588)1032681187 |0 (DE-627)738641200 |0 (DE-576)168441233 |4 aut | |
| 700 | 1 | |a Zweckberger, Klaus |d 1978- |e VerfasserIn |0 (DE-588)13205034X |0 (DE-627)517299534 |0 (DE-576)298915510 |4 aut | |
| 700 | 1 | |a Younsi, Alexander |d 1985- |e VerfasserIn |0 (DE-588)104607508X |0 (DE-627)775681547 |0 (DE-576)39935882X |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t International journal of molecular sciences |d Basel : Molecular Diversity Preservation International, 2000 |g 24(2023), 16, Artikel-ID 12756, Seite 1-17 |h Online-Ressource |w (DE-627)316340715 |w (DE-600)2019364-6 |w (DE-576)281194653 |x 1422-0067 |7 nnas |a The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice |
| 773 | 1 | 8 | |g volume:24 |g year:2023 |g number:16 |g elocationid:12756 |g pages:1-17 |g extent:17 |a The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice |
| 856 | 4 | 0 | |u https://doi.org/10.3390/ijms241612756 |x Verlag |x Resolving-System |z kostenfrei |3 Volltext |
| 856 | 4 | 0 | |u https://www.mdpi.com/1422-0067/24/16/12756 |x Verlag |z kostenfrei |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20231016 | ||
| 993 | |a Article | ||
| 994 | |a 2023 | ||
| 998 | |g 104607508X |a Younsi, Alexander |m 104607508X:Younsi, Alexander |d 910000 |d 911200 |d 50000 |e 910000PY104607508X |e 911200PY104607508X |e 50000PY104607508X |k 0/910000/ |k 1/910000/911200/ |k 0/50000/ |p 10 |y j | ||
| 998 | |g 13205034X |a Zweckberger, Klaus |m 13205034X:Zweckberger, Klaus |d 50000 |e 50000PZ13205034X |k 0/50000/ |p 9 | ||
| 998 | |g 1032681187 |a Unterberg, Andreas |m 1032681187:Unterberg, Andreas |d 910000 |d 911200 |e 910000PU1032681187 |e 911200PU1032681187 |k 0/910000/ |k 1/910000/911200/ |p 8 | ||
| 998 | |g 120568225 |a Skutella, Thomas |m 120568225:Skutella, Thomas |d 50000 |d 53100 |e 50000PS120568225 |e 53100PS120568225 |k 0/50000/ |k 1/50000/53100/ |p 7 | ||
| 998 | |g 1199567183 |a Zheng, Guoli |m 1199567183:Zheng, Guoli |p 6 | ||
| 998 | |g 1218732377 |a Grutza, Martin |m 1218732377:Grutza, Martin |d 910000 |d 911200 |e 910000PG1218732377 |e 911200PG1218732377 |k 0/910000/ |k 1/910000/911200/ |p 5 | ||
| 998 | |g 1193522706 |a Alhalabi, Obada |m 1193522706:Alhalabi, Obada |d 910000 |d 911200 |e 910000PA1193522706 |e 911200PA1193522706 |k 0/910000/ |k 1/910000/911200/ |p 4 | ||
| 998 | |g 1181398878 |a Walter, Johannes |m 1181398878:Walter, Johannes |d 910000 |d 911200 |e 910000PW1181398878 |e 911200PW1181398878 |k 0/910000/ |k 1/910000/911200/ |p 1 |x j | ||
| 999 | |a KXP-PPN1865734195 |e 4389757733 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"person":[{"given":"Johannes","role":"aut","display":"Walter, Johannes","family":"Walter"},{"display":"Mende, Jannis","role":"aut","given":"Jannis","family":"Mende"},{"given":"Samuel","role":"aut","display":"Hutagalung, Samuel","family":"Hutagalung"},{"display":"Alhalabi, Obada","role":"aut","given":"Obada","family":"Alhalabi"},{"family":"Grutza","display":"Grutza, Martin","given":"Martin","role":"aut"},{"display":"Zheng, Guoli","role":"aut","given":"Guoli","family":"Zheng"},{"family":"Skutella","display":"Skutella, Thomas","role":"aut","given":"Thomas"},{"display":"Unterberg, Andreas","role":"aut","given":"Andreas","family":"Unterberg"},{"display":"Zweckberger, Klaus","role":"aut","given":"Klaus","family":"Zweckberger"},{"family":"Younsi","role":"aut","given":"Alexander","display":"Younsi, Alexander"}],"name":{"displayForm":["Johannes Walter, Jannis Mende, Samuel Hutagalung, Obada T. Alhalabi, Martin Grutza, Guoli Zheng, Thomas Skutella, Andreas Unterberg, Klaus Zweckberger and Alexander Younsi"]},"relHost":[{"language":["eng"],"part":{"issue":"16","pages":"1-17","extent":"17","volume":"24","year":"2023","text":"24(2023), 16, Artikel-ID 12756, Seite 1-17"},"title":[{"title_sort":"International journal of molecular sciences","title":"International journal of molecular sciences"}],"pubHistory":["1.2000 -"],"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International"}],"recId":"316340715","titleAlt":[{"title":"IJMS"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"note":["Gesehen am 17.09.20"],"physDesc":[{"extent":"Online-Ressource"}],"disp":"The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in miceInternational journal of molecular sciences","id":{"eki":["316340715"],"issn":["1422-0067","1661-6596"],"zdb":["2019364-6"]}}],"note":["Veröffentlicht: 14. August 2023","Gesehen am 16.10.2023"],"id":{"doi":["10.3390/ijms241612756"],"eki":["1865734195"]},"physDesc":[{"extent":"17 S.","noteIll":"Illustrationen"}],"origin":[{"dateIssuedDisp":"2023","dateIssuedKey":"2023"}],"recId":"1865734195","type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"title":[{"title_sort":"single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice","title":"The single-dose application of interleukin-4 ameliorates secondary brain damage in the early phase after moderate experimental traumatic brain injury in mice"}]} | ||
| SRT | |a WALTERJOHASINGLEDOSE2023 | ||